Money
Ionis Pharmaceuticals' 2026 Catalyst Pipeline: Implications for Stock Valuation
Leerink's recent adjustment of Ionis Pharmaceuticals' target price is influenced by the anticipated catalysts in the company's 2026 pipeline, which may enhance market performance.
Editorial Staff 19 days ago